Antiproliferative effect of pHLIP-amanitin

Area of Science:

• Biotechnology and Pharmaceutical Sciences
• Molecular and Cellular Biology
• Cancer Research

Background:

• Targeted drug delivery remains a significant challenge in cancer therapy.
• Toxins can be effective anticancer agents if selectively delivered to cancer cells.
• pH low insertion peptide (pHLIP) family peptides facilitate membrane translocation.

Purpose of the Study:

• To investigate the use of pHLIP for the pH-dependent delivery of the cell-impermeable toxin alpha-amanitin into cancer cells.
• To evaluate the antiproliferative efficacy of pHLIP-conjugated alpha-amanitin constructs.
• To elucidate the mechanism of toxin translocation and cytoplasmic release.

Main Methods:

• Conjugation of alpha-amanitin to the C-terminus of pHLIP using linkers of varying hydrophobicities.
• Assessment of pHLIP-mediated delivery and antiproliferative effects in four human cancer cell lines at different pH values.
• Analysis of the translocation mechanism and cytoplasmic cleavage of disulfide bonds.

Main Results:

• pHLIP successfully delivered alpha-amanitin into cancer cells in a pH-dependent manner, inducing cell death within 48 hours.
• The pHLIP-SPDP-amanitin construct demonstrated 4-5 times higher antiproliferative activity at pH 6 compared to pH 7.4.
• The primary delivery mechanism involves direct translocation across the cell membrane by pHLIP, followed by cytoplasmic S-S bond cleavage.

Conclusions:

• pHLIP-mediated delivery of alpha-amanitin offers a promising strategy for developing potent, pH-selective anticancer agents.
• This approach selectively targets rapidly proliferating cancer cells, particularly in the acidic tumor microenvironment.
• The developed constructs hold significant potential for advancing targeted cancer therapies.